Gastroretentive Drug Delivery System Market Size, Share, Industry, Forecast and outlook (2023-2030)
Published: 2024 February 01
SKU : PH4003
180 pages
Report Summary
Table of Contents
List of Tables & Figures
Buy this report
Single User
$4350
Multiple User
$4850
Enterprise User
$7850
Request new version
FAQ’s
What are gastroretentive drug delivery systems?
Gastroretentive drug delivery systems are innovative drug delivery systems designed to extend the time a medication stays in the stomach, leading to improved drug absorption and treatment efficacy.
What are the key drivers of the gastroretentive drug delivery systems market?
The market growth is fueled by several factors, including the rising prevalence of gastrointestinal disorders, increasing demand for targeted drug delivery solutions, and the need for improved bioavailability of drugs.
What are the major applications of gastroretentive drug delivery systems?
These systems find applications in treating various stomach and small intestine disorders, including peptic ulcers, gastroesophageal reflux disease (GERD), and Helicobacter pylori infections.
Who are the leading players in the gastroretentive drug delivery systems market?
Key players in the market include Pharmacia, Galenix, Depomed, Ranbaxy, Sun Pharma, Pfizer, Lupin, GlaxoSmithKline, F.Hoffmann La Roche, and Alcon Inc.